Carmela
Gómez Rodríguez
Instituto de Investigación Biomédica de Salamanca
Salamanca, EspañaPublikationen in Zusammenarbeit mit Forschern von Instituto de Investigación Biomédica de Salamanca (2)
2024
-
Randomised, double-blind, placebo-controlled, parallel-group, multicentric, phase IIA clinical trial for evaluating the safety, tolerability, and therapeutic efficacy of daily oral administration of NFX88 to treat neuropathic pain in individuals with spinal cord injury
Spinal Cord, Vol. 62, Núm. 8, pp. 454-467
2013
-
The olfactory system as a puzzle: Playing with its pieces
Anatomical Record, Vol. 296, Núm. 9, pp. 1383-1400